FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362409817> ?p ?o ?g. }

• W4362409817 abstract "<p>A) CT and MRI of patient with prolonged partial response with MTL-CEBPA treatment B) IFN-gamma, NFkB and IL6 trend at days 1, 8 and 15 following treatment and C) AFP change at from baseline to 4, 8 and 16 weeks on treatment</p>" @default.
• W4362409817 created "2023-04-05" @default.
• W4362409817 creator A5002660666 @default.
• W4362409817 creator A5006469214 @default.
• W4362409817 creator A5007167001 @default.
• W4362409817 creator A5007816204 @default.
• W4362409817 creator A5013988479 @default.
• W4362409817 creator A5016820939 @default.
• W4362409817 creator A5017721654 @default.
• W4362409817 creator A5018715910 @default.
• W4362409817 creator A5025272654 @default.
• W4362409817 creator A5025609095 @default.
• W4362409817 creator A5029508585 @default.
• W4362409817 creator A5033419561 @default.
• W4362409817 creator A5034748028 @default.
• W4362409817 creator A5037701629 @default.
• W4362409817 creator A5038487443 @default.
• W4362409817 creator A5040263235 @default.
• W4362409817 creator A5043533251 @default.
• W4362409817 creator A5045076272 @default.
• W4362409817 creator A5046038634 @default.
• W4362409817 creator A5047183768 @default.
• W4362409817 creator A5048419838 @default.
• W4362409817 creator A5059570227 @default.
• W4362409817 creator A5060350068 @default.
• W4362409817 creator A5060429192 @default.
• W4362409817 creator A5063161368 @default.
• W4362409817 creator A5063306410 @default.
• W4362409817 creator A5064596541 @default.
• W4362409817 creator A5073905315 @default.
• W4362409817 creator A5078706966 @default.
• W4362409817 creator A5081217777 @default.
• W4362409817 creator A5082188960 @default.
• W4362409817 creator A5083305101 @default.
• W4362409817 creator A5085052628 @default.
• W4362409817 creator A5089670001 @default.
• W4362409817 creator A5089951951 @default.
• W4362409817 date "2023-03-31" @default.
• W4362409817 modified "2023-10-16" @default.
• W4362409817 title "Supplementary Figure 4 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial" @default.
• W4362409817 doi "https://doi.org/10.1158/1078-0432.22477086" @default.
• W4362409817 hasPublicationYear "2023" @default.
• W4362409817 type Work @default.
• W4362409817 citedByCount "0" @default.
• W4362409817 crossrefType "posted-content" @default.
• W4362409817 hasAuthorship W4362409817A5002660666 @default.
• W4362409817 hasAuthorship W4362409817A5006469214 @default.
• W4362409817 hasAuthorship W4362409817A5007167001 @default.
• W4362409817 hasAuthorship W4362409817A5007816204 @default.
• W4362409817 hasAuthorship W4362409817A5013988479 @default.
• W4362409817 hasAuthorship W4362409817A5016820939 @default.
• W4362409817 hasAuthorship W4362409817A5017721654 @default.
• W4362409817 hasAuthorship W4362409817A5018715910 @default.
• W4362409817 hasAuthorship W4362409817A5025272654 @default.
• W4362409817 hasAuthorship W4362409817A5025609095 @default.
• W4362409817 hasAuthorship W4362409817A5029508585 @default.
• W4362409817 hasAuthorship W4362409817A5033419561 @default.
• W4362409817 hasAuthorship W4362409817A5034748028 @default.
• W4362409817 hasAuthorship W4362409817A5037701629 @default.
• W4362409817 hasAuthorship W4362409817A5038487443 @default.
• W4362409817 hasAuthorship W4362409817A5040263235 @default.
• W4362409817 hasAuthorship W4362409817A5043533251 @default.
• W4362409817 hasAuthorship W4362409817A5045076272 @default.
• W4362409817 hasAuthorship W4362409817A5046038634 @default.
• W4362409817 hasAuthorship W4362409817A5047183768 @default.
• W4362409817 hasAuthorship W4362409817A5048419838 @default.
• W4362409817 hasAuthorship W4362409817A5059570227 @default.
• W4362409817 hasAuthorship W4362409817A5060350068 @default.
• W4362409817 hasAuthorship W4362409817A5060429192 @default.
• W4362409817 hasAuthorship W4362409817A5063161368 @default.
• W4362409817 hasAuthorship W4362409817A5063306410 @default.
• W4362409817 hasAuthorship W4362409817A5064596541 @default.
• W4362409817 hasAuthorship W4362409817A5073905315 @default.
• W4362409817 hasAuthorship W4362409817A5078706966 @default.
• W4362409817 hasAuthorship W4362409817A5081217777 @default.
• W4362409817 hasAuthorship W4362409817A5082188960 @default.
• W4362409817 hasAuthorship W4362409817A5083305101 @default.
• W4362409817 hasAuthorship W4362409817A5085052628 @default.
• W4362409817 hasAuthorship W4362409817A5089670001 @default.
• W4362409817 hasAuthorship W4362409817A5089951951 @default.
• W4362409817 hasBestOaLocation W43624098171 @default.
• W4362409817 hasConcept C104317684 @default.
• W4362409817 hasConcept C121608353 @default.
• W4362409817 hasConcept C126322002 @default.
• W4362409817 hasConcept C143998085 @default.
• W4362409817 hasConcept C3019800554 @default.
• W4362409817 hasConcept C45091340 @default.
• W4362409817 hasConcept C501734568 @default.
• W4362409817 hasConcept C502942594 @default.
• W4362409817 hasConcept C535046627 @default.
• W4362409817 hasConcept C55493867 @default.
• W4362409817 hasConcept C71924100 @default.
• W4362409817 hasConcept C86803240 @default.
• W4362409817 hasConceptScore W4362409817C104317684 @default.
• W4362409817 hasConceptScore W4362409817C121608353 @default.
• W4362409817 hasConceptScore W4362409817C126322002 @default.
• W4362409817 hasConceptScore W4362409817C143998085 @default.
• W4362409817 hasConceptScore W4362409817C3019800554 @default.
• W4362409817 hasConceptScore W4362409817C45091340 @default.
• W4362409817 hasConceptScore W4362409817C501734568 @default.

• next